Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest

DOI10.2202/1544-6115.1345zbMATH Open1276.62064OpenAlexW1523050196WikidataQ33321921 ScholiaQ33321921MaRDI QIDQ2864016FDOQ2864016

Authors: Somnath Datta 

Publication date: 5 December 2013

Published in: Statistical Applications in Genetics and Molecular Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2202/1544-6115.1345

Recommendations

• Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
• A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
• Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
• A classification model for the Leiden proteomics competition
• Feature selection and machine learning with mass spectrometry data for distinguishing cancer and non-cancer samples

Mathematics Subject Classification ID

Classification and discrimination; cluster analysis (statistical aspects) (62H30) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Cited In (13)

• Principal component discriminant analysis
• Feature selection and machine learning with mass spectrometry data for distinguishing cancer and non-cancer samples
• A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
• A classification model for the Leiden proteomics competition
• Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
• A new genetic algorithm in proteomics: feature selection for SELDI-TOF data
• Bayesian nonparametric classification for spectroscopy data
• Support vector machine approach to separate control and breast cancer serum samples
• A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
• Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
• Prototype based fuzzy classification in clinical proteomics
• Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
• Binary Markov random fields and interpretable mass spectra discrimination

This page was built for publication: Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2864016)